glp 1 agonist effects GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes Clinical Recommendations to Manage Gastrointestinal
Description
WNT5A enhances LH-mediated expression of HAS2 in granulosa cells
GLP-1 increased cAMP but did not affect amylase secretion
Endocrinology (2004) 145:268795
7 As the benefits of the GLP-1 receptor agonists with T2D, obesity, and cardiovascular health are becoming widely known, research into using these agents to treat other conditions has accelerated
